DOTA, with a full name of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, is an organic compound. Its not a cancer cell surface molecule biomarker, but usually used as a complexing agent, especially for lanthanide ions. Its complexes have medical applications as contrast agents and cancer treatments.DOTA can be conjugated to monoclonal antibodies by attachment of one of the four carboxyl groups as an amide. The remaining three carboxylate anions are available for binding to the yttrium ion. The modified antibody accumulates in the tumour cells, concentrating the effects of the radioactivity of 90Y.

Associated Disease
  • Various cancer cells stained with DOTA-labeled antibodies
  • Others
  • CAR Vector Products
  • CAR Viral Particles
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type Inquiry & Datasheet
CAR-LC059 Anti-DOTA h(41BB-CD3ζ) CAR, pCDCAR1 Mouse scFv-41BB-CD3ζ Lentiviral T cell   Add to Cart   Datasheet
CAR-ZP2750 Anti-DOTA (CAR-ZP2750) h(CD28-CD3ζ) CAR, pCDCAR1 Plasmodium CAR-ZP2750 Rabbit scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-ZP2751 Anti-DOTA (CAR-ZP2750) h(41BB-CD3ζ) CAR, pCDCAR1 Plasmodium CAR-ZP2750 Rabbit scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet

Key Updates

Receive our latest news and insights.